Strs Ohio Kymera Therapeutics, Inc. Transaction History

Strs Ohio

$25.5 Billion
Q3 2024

A detailed history of Strs Ohio transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Strs Ohio holds 9,600 shares of KYMR stock, worth $441,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

9,600

Previous 9,600 -0.0%

Holding current value

$441,120

Previous $286,000 58.74%

% of portfolio

0.0%

Previous 0.0%

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$29.85 - $39.42 $286,560 - $378,432	9,600 New	9,600 $286,000
Q2 2022 Jul 25, 2022	SELL	$14.13 - $42.55 $76,302 - $229,769	-5,400 Reduced 31.4%	11,800 $232,000
Q3 2021 Oct 22, 2021	BUY	$47.8 - $66.66 $143,400 - $199,980	3,000 Added 21.13%	17,200 $1.01 Million
Q2 2021 Jul 26, 2021	BUY	$31.08 - $51.95 $180,264 - $301,310	5,800 Added 69.05%	14,200 $688,000
Q1 2021 Apr 23, 2021	BUY	$35.64 - $85.46 $210,276 - $504,213	5,900 Added 236.0%	8,400 $326,000
Q4 2020 Jan 25, 2021	BUY	$28.07 - $87.83 $70,175 - $219,575	2,500 New	2,500 $155,000

Others Institutions Holding KYMR

# of Institutions

181

Shares Held

64.4M

Call Options Held

45.1K

Put Options Held

32.6K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $2.51B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account